HomeHealthcare & Life SciencesBiotechnology Preimplantation Genetic Testing Market

Middle East And Africa Preimplantation Genetic Testing Market Size & Outlook, 2025-2033


Middle East And Africa Preimplantation Genetic Testing Market Insights

  • Based on Reed Intelligence findings, the Middle East And Africa Preimplantation Genetic Testing Market size reached USD 74.04 Million in 2024 and is expected to grow to USD 137.18 Million by 2033.
  • During 2026–2033, the market is forecasted to advance at a CAGR of 7.09%.
  • Preimplantation Genetic Screening (PGS) represented the largest share of the By Procedure market in terms of size in 2024.
  • Among the By Procedure segments, Preimplantation Genetic Screening (PGS) is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • The global Preimplantation Genetic Testing Market size saw Middle East And Africa holding a share of 8.73% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In Middle East and Africa, South Africa is forecasted to be the fastest-expanding market, projected to reach USD 11.51 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 74.04 Million
Market Size In 2033 USD 137.18 Million
Largest segment Preimplantation Genetic Screening (PGS)
Units Revenue in USD Million
CAGR 7.09% (2025-2033)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
By Procedure
  1. Preimplantation Genetic Screening (PGS)
  2. Preimplantation Genetic Diagnosis (PGD)
By Product
  1. Reagents and Consumables
  2. Instruments
  3. Software
By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Fluorescent In Situ Hybridisation (FISH)
  4. Others
By Application
  1. Chromosomal Abnormalities
  2. Aneuploidy Screening
  3. X-linked Diseases
  4. Embryo Testing
  5. Human Leukocyte Antigen (HLA) Typing
  6. Others
By End-User
  1. Hospitals
  2. Fertility Centres
  3. Diagnostic Centres
  4. Research Centres and Academic Labs
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports